- info@myglp1store.com
- +1 (904) 942-2327
- 6953 Powers avenue suite 19 Jacksonville Fl 32217
Need Any Help?
+1 (904) 942-2327
+1 (904) 942-2327
Price range: $69.00 through $662.40
Semaglutide is a synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 receptor signaling pathways. It is intended strictly for experimental research applications and is not approved for human or veterinary use.
Ingredients / Composition:
| Component | Description |
|---|---|
| Active Compound | Semaglutide (synthetic GLP-1 receptor agonist peptide) |
| Net Peptide Content | 5 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry where applicable |
Semaglutide is referenced in scientific literature for studies exploring receptor binding behavior, intracellular signaling activation, and metabolic pathway modulation. All references to published research are provided strictly for scientific context and do not represent administration or usage guidance.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Semaglutide is an investigational GLP-1 receptor agonist peptide utilized in metabolic and endocrine pathway research.
Its molecular structure allows researchers to study ligand-receptor interactions and downstream intracellular signaling events associated with incretin hormone pathways under controlled laboratory conditions.
Within research environments, Semaglutide may be incorporated into experimental systems designed to evaluate:
Receptor affinity and activation kinetics
Cyclic AMP and secondary messenger signaling responses
Gene expression changes associated with GLP-1 pathway engagement
Comparative peptide structure-activity relationships
Stability and degradation characteristics of peptide compounds
These investigations support a broader understanding of incretin-related signaling networks and cellular metabolic response mechanisms.
Semaglutide may be used in laboratory studies involving:
Receptor binding assays
Cell-based functional response testing
Signal transduction pathway analysis
Peptide pharmacology modeling
Comparative GLP-1 analog research
Its consistent molecular profile supports reproducibility across controlled experimental protocols.
Compound: Semaglutide (Research Grade)
Net Content: 5 mg per vial
Form: Lyophilized peptide powder
Analytical Verification: Identity and purity confirmed using laboratory methods such as HPLC and mass spectrometry where applicable
Storage: Store under laboratory-appropriate cold storage conditions
Each vial is prepared to support precise laboratory measurement and experimental consistency.
This product is provided exclusively for research and laboratory use.
Not intended for:
Human consumption
Animal use
Diagnostic purposes
Therapeutic or clinical applications
No physiological outcomes, medical effects, or performance benefits are implied or guaranteed. All purchasers are responsible for ensuring compliance with institutional protocols, ethical standards, and applicable regulatory requirements when handling investigational compounds.
Semaglutide is supplied as an Antagonist to support scientific exploration of GLP-1 receptor mechanisms and metabolic signaling pathways.
Semaglutide is a synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 receptor signaling pathways. It is intended strictly for experimental research applications and is not approved for human or veterinary use.
Ingredients / Composition:
| Component | Description |
|---|---|
| Active Compound | Semaglutide (synthetic GLP-1 receptor agonist peptide) |
| Net Peptide Content | 5 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry where applicable |
Semaglutide is referenced in scientific literature for studies exploring receptor binding behavior, intracellular signaling activation, and metabolic pathway modulation. All references to published research are provided strictly for scientific context and do not represent administration or usage guidance.
Reviews
There are no reviews yet.